Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-25-000833
Filing Date
2025-01-10
Accepted
2025-01-10 16:15:50
Documents
2
Period of Report
2025-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 8777
2 EXHIBIT 24 ef20041345_ex24.htm EX-24 9901
  Complete submission text file 0001140361-25-000833.txt   20175
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATAI LIFE SCIENCES N.V. WALLSTRASSE 16 BERLIN 2M 10179
Business Address
Craig Kevin James (Reporting) CIK: 0002049601 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40493 | Film No.: 25523166